We’ve known for a while that when pharmaceutical manufacturers provide incentives to doctors to prescribe opioids, they prescribe opioids. This isn’t anything new. But according to research just published at JAMA Network Open, there is a direct connection between the payments that drug companies give to opioid prescribers and an increase in overdoses in those prescribers’ communities.

read more...